links 11/19/25: https://roamresearch.com/#/app/srcpublic/page/11-19-2025
https://www.corememory.com/p/exclusive-a-bold-new-bid-to-control-genome-generalcontrol [[Lada Nuzhna]] has a company based on a CRISPR variant for multiplex epigenetic editing. they're going after obesity, sarcopenia, and fibrosis, and they have a Novo Nordisk partnership.